Literature DB >> 17334655

Faithful tissue-specific expression of the human chromosome 21-linked COL6A1 gene in BAC-transgenic mice.

Luzhou Xing1, Martha Salas, Chyuan-Sheng Lin, Warren Zigman, Wayne Silverman, Shivakumar Subramaniyam, Vundavalli V Murty, Benjamin Tycko.   

Abstract

We created transgenic mice with a bacterial artificial chromosome (BAC) containing the human COL6A1 gene. In high-copy and low-copy transgenic lines, we found correct temporal and spatial expression of COL6A1 mRNA, paralleling the expression of the murine Col6a1 gene in a panel of nine adult and four fetal organs. The only exception was the fetal lung, in which the transgene was expressed poorly compared with the endogenous gene. Expression of COL6A1 mRNA from the transgene was copy number-dependent, and the increased gene dosage correlated with increased production of collagen VI alpha 1 in skin and heart, as indicated by Western blotting and immunohistochemistry. COL6A1 maps to Chromosome 21 and this gene has been a candidate for contributing to cardiac defects and skin abnormalities in Down syndrome. The low-copy and high-copy COL6A1 transgenics were born and survived in normal Mendelian proportions, without cardiac malformations or altered skin histology. These data indicate that the major promoter and enhancer sequences regulating COL6A1 expression are present in this 167-kb BAC clone. The lack of a strong cardiac or skin phenotype in the COL6A1 BAC-transgenic mice suggests that the increased expression of this gene does not, by itself, account for these phenotypes in Down syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334655     DOI: 10.1007/s00335-006-0082-y

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   3.224


  30 in total

1.  Genomewide linkage and linkage disequilibrium analyses identify COL6A1, on chromosome 21, as the locus for ossification of the posterior longitudinal ligament of the spine.

Authors:  Toshihiro Tanaka; Katsunori Ikari; Kozo Furushima; Akihiro Okada; Hiroshi Tanaka; Ken-Ichi Furukawa; Kenichi Yoshida; Toshiyuki Ikeda; Shiro Ikegawa; Steven C Hunt; Jun Takeda; Satoshi Toh; Seiko Harata; Toshiaki Nakajima; Ituro Inoue
Journal:  Am J Hum Genet       Date:  2003-09-04       Impact factor: 11.025

2.  Development of NG2 neural progenitor cells requires Olig gene function.

Authors:  Keith L Ligon; Santosh Kesari; Masaaki Kitada; Tao Sun; Heather A Arnett; John A Alberta; David J Anderson; Charles D Stiles; David H Rowitch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

3.  Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome.

Authors:  D J Smith; M E Stevens; S P Sudanagunta; R T Bronson; M Makhinson; A M Watabe; T J O'Dell; J Fung; H U Weier; J F Cheng; E M Rubin
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

4.  Distribution of extracellular matrix components in nuchal skin from fetuses carrying trisomy 18 and trisomy 21.

Authors:  B Brand-Saberi; H H Epperlein; G E Romanos; B Christ
Journal:  Cell Tissue Res       Date:  1994-09       Impact factor: 5.249

5.  Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures.

Authors:  G J Jöbsis; H Keizers; J P Vreijling; M de Visser; M C Speer; R A Wolterman; F Baas; P A Bolhuis
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

6.  Refining chromosomal region critical for Down syndrome-related heart defects with a case of cryptic 21q22.2 duplication.

Authors:  Rika Kosaki; Kenjiro Kosaki; Kazushige Matsushima; Norimasa Mitsui; Naomichi Matsumoto; Hirofumi Ohashi
Journal:  Congenit Anom (Kyoto)       Date:  2005-06       Impact factor: 1.409

7.  Twofold overexpression of human beta-amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive, or neurodegenerative sequelae following experimental brain injury.

Authors:  H Murai; J E Pierce; R Raghupathi; D H Smith; K E Saatman; J Q Trojanowski; V M Lee; J F Loring; C Eckman; S Younkin; T K McIntosh
Journal:  J Comp Neurol       Date:  1998-03-23       Impact factor: 3.215

8.  Collagen type VI expression during cardiac development and in human fetuses with trisomy 21.

Authors:  Adriana C Gittenberger-de Groot; Ulrike Bartram; Petra W Oosthoek; Margot M Bartelings; Bianca Hogers; Robert E Poelmann; Ian N Jongewaard; Scott E Klewer
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2003-12

9.  Expression of the human beta-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice.

Authors:  B E Pearson; T K Choi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

10.  NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.

Authors:  Joseph R Arron; Monte M Winslow; Alberto Polleri; Ching-Pin Chang; Hai Wu; Xin Gao; Joel R Neilson; Lei Chen; Jeremy J Heit; Seung K Kim; Nobuyuki Yamasaki; Tsuyoshi Miyakawa; Uta Francke; Isabella A Graef; Gerald R Crabtree
Journal:  Nature       Date:  2006-03-22       Impact factor: 49.962

View more
  6 in total

1.  Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1).

Authors:  Luzhou Xing; Martha Salas; Hong Zhang; Julia Gittler; Thomas Ludwig; Chyuan-Sheng Lin; Vundavalli V Murty; Wayne Silverman; Ottavio Arancio; Benjamin Tycko
Journal:  Mamm Genome       Date:  2012-10-25       Impact factor: 2.957

2.  Epigenetic deregulation of the human Oct4 promoter in mouse cells.

Authors:  Young Cha; Min-Kyung Sung; Kyung-Won Jung; Hwan-Hee Kim; Su-Man Lee; Kyung-Soon Park
Journal:  Dev Genes Evol       Date:  2008-09-23       Impact factor: 0.900

3.  Over-expression of DSCAM and COL6A2 cooperatively generates congenital heart defects.

Authors:  Tamar R Grossman; Amir Gamliel; Robert J Wessells; Ouarda Taghli-Lamallem; Kristen Jepsen; Karen Ocorr; Julie R Korenberg; Kirk L Peterson; Michael G Rosenfeld; Rolf Bodmer; Ethan Bier
Journal:  PLoS Genet       Date:  2011-11-03       Impact factor: 5.917

Review 4.  Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models.

Authors:  Catherine Do; Zhuo Xing; Y Eugene Yu; Benjamin Tycko
Journal:  Epigenomics       Date:  2016-12-02       Impact factor: 4.778

5.  Regulated expression of a transgene introduced on an oriP/EBNA-1 PAC shuttle vector into human cells.

Authors:  Hanne A Askautrud; Elisabet Gjernes; Gro L Størvold; Mona M Lindeberg; Jim Thorsen; Hans Prydz; Eirik Frengen
Journal:  BMC Biotechnol       Date:  2009-10-16       Impact factor: 2.563

6.  Transchromosomic cell model of Down syndrome shows aberrant migration, adhesion and proteome response to extracellular matrix.

Authors:  Frédéric Delom; Emma Burt; Alex Hoischen; Joris Veltman; Jürgen Groet; Finbarr E Cotter; Dean Nizetic
Journal:  Proteome Sci       Date:  2009-08-28       Impact factor: 2.480

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.